Literature DB >> 29911960

Liver Transplant for Perihilar Cholangiocarcinoma (Klatskin Tumor): The Essential Role of Patient Selection.

Felix Dondorf1, Frank Uteβ, René Fahrner, Philipp Felgendreff, Michael Ardelt, Hans-Michael Tautenhahn, Utz Settmacher, Falk Rauchfuβ.   

Abstract

OBJECTIVES: Perihilar cholangiocarcinoma (Klatskin tumor) is a rare tumor entity, which is diagnosed late due to uncharacteristic symptoms. The therapeutic strategy for cure is still liver resection. Liver transplant in cases of locally irresectable tumors represents an alternative potential curative therapy for a select group of patients.
MATERIALS AND METHODS: We present our data of 22 patients with irresectable Klatskin tumors who received transplants between 1996 and 2015. We analyzed relevant prognostic factors for the selection of patients to be transplanted to ensure an acceptable overall survival and reviewed known and established selection criteria.
RESULTS: Four factors (age, tumor size, serum level of carbohydrate antigen 19-9, percutaneous transhepatic cholangiodrainage) could be detected for possible patient selection. Positive lymph node status and advanced tumor stage according to the Union for International Cancer Control were confirmed as negative prognostic factors for survival after transplant.
CONCLUSIONS: Liver transplant is a curative therapy for selected patients with irresectable Klatskin tumors, but further prospective studies are urgently needed.

Entities:  

Year:  2018        PMID: 29911960     DOI: 10.6002/ect.2018.0024

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  3 in total

1.  Risk of malignancy in Caroli disease and syndrome: A systematic review.

Authors:  René Fahrner; Sandra Gc Dennler; Daniel Inderbitzin
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

Review 2.  Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature.

Authors:  Susumu Eguchi; Masaaki Hidaka; Takanobu Hara; Hajime Matsushima; Akihiko Soyama
Journal:  Ann Gastroenterol Surg       Date:  2022-03-23

Review 3.  Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?

Authors:  Alice Boilève; Marc Hilmi; Matthieu Delaye; Annemilaï Tijeras-Raballand; Cindy Neuzillet
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.